Sadia Munir
Higher Degree by Research Candidate
School of Biomedicine
Faculty of Health and Medical Sciences
Dose limiting toxicities of anti-cancer drugs associated with their systemic distribution after administration are a major limitation in treating many cancers including myeloma. During my PhD candidature, I am developing and investigating novel approaches, including state-of-the-art nanoparticle system and novel vascular-modulating agents to selectively increase the delivery of anti-myeloma drugs to the site of tumour to reduce their side-effects.
Title: development ans assessment of novel drug delivery stratigies to treat multiple myeloma
-
Appointments
Date Position Institution name 2008 - 2016 Technical support specialist Jomar Life Research -
Language Competencies
Language Competency Urdu Can read, write, speak and understand spoken -
Education
Date Institution name Country Title 2020 University of Adelaide Australia PhD 2006 - 2008 Flinders University Australia Masters in Biotechnology Studies -
Research Interests
Connect With Me
External Profiles